These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9191625)

  • 21. [Methods for cost-effectiveness evaluation of intensive care].
    Heslet L; Andersen JS; Keiding H
    Ugeskr Laeger; 2007 Feb; 169(8):721-4. PubMed ID: 17313927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preferences for health outcomes and cost-utility analysis.
    Torrance GW
    Am J Manag Care; 1997 May; 3 Suppl():S8-20. PubMed ID: 10180342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Determining the possibility of collecting reliable data for use in decision making in health care on the example of cost-effectiveness analysis of methods used in smoking cessation].
    Bała M
    Przegl Lek; 2004; 61(10):1180-3. PubMed ID: 15794284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of cost-effectiveness analysis to multiple products: a practical guide.
    Bala MV; Zarkin GA
    Am J Manag Care; 2002 Mar; 8(3):211-8. PubMed ID: 11915971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population-based and opportunistic screening and eradication of Helicobacter pylori. An analysis using trial baseline data. Leeds H. pylori Study Group.
    Mason JM; Moayyedi P; Young PJ; Duffett S; Crocombe W; Drummond MF; Axon AT
    Int J Technol Assess Health Care; 1999; 15(4):649-60. PubMed ID: 10645106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dyspepsia management in primary care: a decision analysis of competing strategies.
    Spiegel BM; Vakil NB; Ofman JJ
    Gastroenterology; 2002 May; 122(5):1270-85. PubMed ID: 11984514
    [No Abstract]   [Full Text] [Related]  

  • 27. [Quality of life linked to health in medical economic studies].
    Hosseini K
    Soins; 2011 Oct; (759):43-4. PubMed ID: 22145438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On cost-benefit and cost-effectiveness analyses.
    NIHAE Bull; 1976; 9(3):166-8. PubMed ID: 829269
    [No Abstract]   [Full Text] [Related]  

  • 29. Cost-effectiveness decision making and US public opinion.
    Botta MD; Blendon RJ; Benson JM
    JAMA Intern Med; 2014 Jan; 174(1):141-3. PubMed ID: 24100698
    [No Abstract]   [Full Text] [Related]  

  • 30. [A care program for primary health care: improved care of patients with dyspepsia].
    Lennholm B
    Lakartidningen; 1996 Oct; 93(44):3892-6. PubMed ID: 8965575
    [No Abstract]   [Full Text] [Related]  

  • 31. Nonulcer dyspepsia and proton pump inhibitors.
    Waldum HL; Martinsen TC; Brenna E
    Gastroenterology; 2005 Mar; 128(3):805; author reply 805-6. PubMed ID: 15765429
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical and economic consequences of dyspepsia in the community.
    Moayyedi P; Mason J
    Gut; 2002 May; 50 Suppl 4(Suppl 4):iv10-2. PubMed ID: 11953338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic analysis of dyspepsia.
    Sonnenberg A
    Eur J Gastroenterol Hepatol; 1997 Apr; 9(4):323-6. PubMed ID: 9160191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health care cost-benefit and cost-effectiveness analysis: an overview.
    Yin D; Forman HP
    J Vasc Interv Radiol; 1995; 6(3):311-20. PubMed ID: 7647430
    [No Abstract]   [Full Text] [Related]  

  • 35. Should indirect costs and benefits be included?
    Henry DA
    Pharmacoeconomics; 1992 Jun; 1(6):462. PubMed ID: 10147025
    [No Abstract]   [Full Text] [Related]  

  • 36. [Wrong scientific techniques in health policy analyses].
    Høiseth A
    Tidsskr Nor Laegeforen; 2003 Apr; 123(8):1111-2. PubMed ID: 12760233
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cost-effectiveness analysis for diabetes care].
    Fukuda H
    Nihon Rinsho; 2016 Apr; 74 Suppl 2():707-12. PubMed ID: 27266179
    [No Abstract]   [Full Text] [Related]  

  • 38. Weighing the economic evidence: guidelines for critical assessment of cost-effectiveness analyses.
    Ramsey SD; Sullivan SD
    J Am Board Fam Pract; 1999; 12(6):477-85. PubMed ID: 10612366
    [No Abstract]   [Full Text] [Related]  

  • 39. Cost-effectiveness acceptability curves in the dock: case not proven?
    Fenwick E; Briggs A
    Med Decis Making; 2007; 27(2):93-5. PubMed ID: 17409358
    [No Abstract]   [Full Text] [Related]  

  • 40. Letter: East-West differences in the economic impact of functional dyspepsia.
    Mahadeva S; Goh KL
    Aliment Pharmacol Ther; 2013 Sep; 38(6):655. PubMed ID: 23964735
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.